Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2024-02-15 | 2024-05-30 | 219677 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Actual shortage | 2024-06-13 | 2025-05-02 | 230320 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Actual shortage | 2024-08-08 | 2025-04-24 | 234873 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-11 | 1143 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-11-30 | 2024-01-11 | 211976 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-02-08 | 2024-06-20 | 218952 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-02-08 | 2025-03-20 | 218955 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-07-11 | 2024-10-11 | 232741 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-11-08 | 2025-03-27 | 242349 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Resolved | 2020-01-24 | 2020-07-10 | 104336 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-01-30 | 2020-12-03 | 104914 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-02-13 | 2020-04-09 | 106018 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-07-27 | 2023-08-04 | 200231 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-08-17 | 2023-12-14 | 202239 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-04-23 | 2020-11-26 | 113034 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2020-04-03 | 2020-05-29 | 110755 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-14 | 113013 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |